329 related articles for article (PubMed ID: 26831073)
1. Huntingtin exon 1 fibrils feature an interdigitated β-hairpin-based polyglutamine core.
Hoop CL; Lin HK; Kar K; Magyarfalvi G; Lamley JM; Boatz JC; Mandal A; Lewandowski JR; Wetzel R; van der Wel PC
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1546-51. PubMed ID: 26831073
[TBL] [Abstract][Full Text] [Related]
2. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core.
Lin HK; Boatz JC; Krabbendam IE; Kodali R; Hou Z; Wetzel R; Dolga AM; Poirier MA; van der Wel PCA
Nat Commun; 2017 May; 8():15462. PubMed ID: 28537272
[TBL] [Abstract][Full Text] [Related]
3. Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance.
Hoop CL; Lin HK; Kar K; Hou Z; Poirier MA; Wetzel R; van der Wel PC
Biochemistry; 2014 Oct; 53(42):6653-66. PubMed ID: 25280367
[TBL] [Abstract][Full Text] [Related]
4. β-hairpin-mediated nucleation of polyglutamine amyloid formation.
Kar K; Hoop CL; Drombosky KW; Baker MA; Kodali R; Arduini I; van der Wel PC; Horne WS; Wetzel R
J Mol Biol; 2013 Apr; 425(7):1183-97. PubMed ID: 23353826
[TBL] [Abstract][Full Text] [Related]
5. Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils.
Isas JM; Langen R; Siemer AB
Biochemistry; 2015 Jun; 54(25):3942-9. PubMed ID: 26020223
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences.
Lakhani VV; Ding F; Dokholyan NV
PLoS Comput Biol; 2010 Apr; 6(4):e1000772. PubMed ID: 20442863
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of Huntingtin Fibril Polymorphism Revealed by Cryogenic Electron Microscopy of Exon 1 HTT Fibrils.
Nazarov S; Chiki A; Boudeffa D; Lashuel HA
J Am Chem Soc; 2022 Jun; 144(24):10723-10735. PubMed ID: 35679155
[TBL] [Abstract][Full Text] [Related]
8. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.
Nucifora LG; Burke KA; Feng X; Arbez N; Zhu S; Miller J; Yang G; Ratovitski T; Delannoy M; Muchowski PJ; Finkbeiner S; Legleiter J; Ross CA; Poirier MA
J Biol Chem; 2012 May; 287(19):16017-28. PubMed ID: 22433867
[TBL] [Abstract][Full Text] [Related]
10. Selective observation of semi-rigid non-core residues in dynamically complex mutant huntingtin protein fibrils.
Matlahov I; Boatz JC; van der Wel PCA
J Struct Biol X; 2022; 6():100077. PubMed ID: 36419510
[TBL] [Abstract][Full Text] [Related]
11. Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.
Jayaraman M; Kodali R; Sahoo B; Thakur AK; Mayasundari A; Mishra R; Peterson CB; Wetzel R
J Mol Biol; 2012 Feb; 415(5):881-99. PubMed ID: 22178474
[TBL] [Abstract][Full Text] [Related]
12. Architecture of polyglutamine-containing fibrils from time-resolved fluorescence decay.
Röthlein C; Miettinen MS; Borwankar T; Bürger J; Mielke T; Kumke MU; Ignatova Z
J Biol Chem; 2014 Sep; 289(39):26817-26828. PubMed ID: 25092288
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.
Drombosky KW; Rode S; Kodali R; Jacob TC; Palladino MJ; Wetzel R
Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891
[TBL] [Abstract][Full Text] [Related]
14. Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.
Sahoo B; Arduini I; Drombosky KW; Kodali R; Sanders LH; Greenamyre JT; Wetzel R
PLoS One; 2016; 11(6):e0155747. PubMed ID: 27271685
[TBL] [Abstract][Full Text] [Related]
15. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
Wetzel R
Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
[TBL] [Abstract][Full Text] [Related]
16. Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.
van der Wel PCA
Biochem Soc Trans; 2024 Apr; 52(2):719-731. PubMed ID: 38563485
[TBL] [Abstract][Full Text] [Related]
17. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.
Scherzinger E; Sittler A; Schweiger K; Heiser V; Lurz R; Hasenbank R; Bates GP; Lehrach H; Wanker EE
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4604-9. PubMed ID: 10200309
[TBL] [Abstract][Full Text] [Related]
18. Structure of a single-chain Fv bound to the 17 N-terminal residues of huntingtin provides insights into pathogenic amyloid formation and suppression.
De Genst E; Chirgadze DY; Klein FA; Butler DC; Matak-Vinković D; Trottier Y; Huston JS; Messer A; Dobson CM
J Mol Biol; 2015 Jun; 427(12):2166-78. PubMed ID: 25861763
[TBL] [Abstract][Full Text] [Related]
19. Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization.
Poirier MA; Li H; Macosko J; Cai S; Amzel M; Ross CA
J Biol Chem; 2002 Oct; 277(43):41032-7. PubMed ID: 12171927
[TBL] [Abstract][Full Text] [Related]
20. Aggregation behavior of chemically synthesized, full-length huntingtin exon1.
Sahoo B; Singer D; Kodali R; Zuchner T; Wetzel R
Biochemistry; 2014 Jun; 53(24):3897-907. PubMed ID: 24921664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
